SoftBank wants to push Neumann out of the CEO role ahead of the IPO.Technologyread more
The next three weeks are among the rockiest, on a historical basis, of the entire calendar.Trading Nationread more
Microsoft is looking for a new way to grab business from retailers as they fend off Amazon.Technologyread more
The UK's Civil Aviation Authority said Thomas Cook had now ceased trading and the regulator would work with the government to bring the more than 150,000 British customers...Europe Marketsread more
The holidays are a critical time for many brands, as sales during this time of year can make up 30% of a retailers annual sales. Heading into the gift-giving season, shoppers...Retailread more
An annual survey by Piper Jaffray found iPhone users willing to upgrade to newly released models declined compared to last year.Technologyread more
Banks have historically used armies of mortgage brokers to gather income and asset documents from prospective borrowers.Financeread more
Guggenheim reiterates its buy rating on Boston Beer's stock and raises its price target to $462 from $449 per share.Investingread more
On-demand delivery company Postmates is partnering with Phantom Auto, an autonomous vehicle teleoperator, to coordinate driverless deliveries.Autosread more
Oprah Winfrey is bringing her famed book club to Apple's new streaming subscription service.Technologyread more
Bruce Broussard, CEO of health insurance company Humana, sits down with CNBC's Bertha Coombs to discuss the state of the industry, integrating digital health technology,...Squawk Boxread more
Andy Page, formerly president of Google-backed 23andMe, is joining Livongo, a chronic disease management start-up, as its president and chief financial officer.
Livongo's goal is to help patients with diabetes manage their disease before they end up getting seriously ill. The idea is to suggest lifestyle or medication changes well before the user ends up in the emergency room.
It does this by offering a blood glucose monitor and unlimited supplies like strips to those with diabetes, and monitoring their condition over time. A Livongo coach is available at all times to provide actionable feedback if the readings are outside of normal bounds. If there's no sign of improvement, a specialist might step in.
"The idea is to reduce strain on the health-care system," said Page, who left 23andMe earlier this year. The company presented data at the American Diabetes Association's annual meeting to demonstrate that it saved $83 per participant per month on health-care costs, which was 5.8 percent lower than those not enrolled in its program.
Livongo works with payers, such as self-insured employers like Pepsi and FedEx, that are looking for ways to reduce health costs, and sells its diabetes management program directly to consumers for $49.99 per month.
Some 30 million people in the U.S. have diabetes.
The company is looking to expand into monitoring other chronic conditions, including hypertension and depression.
Livongo CEO Glen Tullman left his role as the chief executive officer for Allscripts, a multibillion-dollar health IT company, to start Livongo in 2014. Tullman has seen firsthand the challenges of managing chronic ailments as the parent of a son with type 1 diabetes. Since then, Livongo has raised more than $140 million in venture capital financing.
Page didn't rule out an initial public offering, saying it would be "consistent" with Tullman's background.
Other start-ups in the space include Vida Health, founded by former Google vice president Stephanie Tilenius, and Andreessen Horowitz-backed Omada Health.